Characteristic | OR1 | 95% CI2 | p | AOR3 | 95% CI2 | p |
---|---|---|---|---|---|---|
Gender (female vs. male) | 0.70 | 0.56 – 0.88 | 0.002 | 0.77 | 0.68 – 0.87 | 0.038 |
Age (per 10 years older) | 2.04 | 1.75 – 2.38 | <0.001 | 1.66 | 1.54 – 1.80 | <0.001 |
Caucasian (yes vs. no) | 1.37 | 1.12 – 1.69 | 0.002 | 1.07 | 0.95 – 1.19 | 0.571 |
Heroin injection (yes vs. no)4 | 0.67 | 0.58 – 0.78 | <0.001 | 0.76 | 0.67 – 0.85 | 0.002 |
Cocaine injection (yes vs. no)4 | 0.73 | 0.63 – 0.85 | <0.001 | 0.74 | 0.66 – 0.83 | 0.001 |
Amphetamine injection (yes vs. no)4 | 1.14 | 0.89 – 1.47 | 0.305 | |||
Crack cocaine smoking (yes vs. no)4 | 0.95 | 0.82 – 1.10 | 0.525 | |||
Methadone maintenance therapy (yes vs. no)4 | 1.74 | 1.45 – 2.10 | <0.001 | 1.96 | 1.75 – 2.19 | <0.001 |
Time since ART initiation (per year increase) | 1.08 | 1.06 – 1.11 | <0.001 | 1.02 | 0.99 – 1.04 | 0.090 |
CD4+ cell count at ART initiation (per 100 cells/mL increase) | 0.87 | 0.83 – 0.92 | <0.001 | 0.88 | 0.85 – 0.90 | <0.001 |